Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Table 1 Baseline patient characteristics

From: Circulating cell-free and extracellular vesicles-derived microRNA as prognostic biomarkers in patients with early-stage NSCLC: results from RESTING study

 

n

%

Gender

 F

89

40.1

 M

133

59.9

Age at surgery (yrs)

 Mean ± SD

69 ± 8

 Median [IQ—IIIQ]

70 [63−75]

 Min—max

44 – 85

missing

1

Smoking habit

 Never smoker

29

13.9

 Ex-smoker

128

61.2

 Current smoker

52

24.9

missing

13

 

ECOG PS

 0

149

69.3

 1

57

26.5

 2

9

4.2

missing

7

 

Neo-adjuvant therapy

 No

200

90.5

 Yes

21

9.5

missing

1

 

Type of resection

 Atypical resection

10

9.1

 Pneumectomy

8

3.6

 Lobectomy

193

87.3

missing

1

 

Radicality

 R0

212

96.8

 R1

6

2.7

 R2

1

0.5

missing

3

 

Histological diagnosis

 Adenocarcinoma

179

81.0

 Squamous cell carcinoma

42

19.0

missing

1

 

Pathological stage

 IA

99

46.5

 IB

38

17.8

 IIA

9

4.2

 IIB

27

12.7

 IIIA

40

18.8

missing

9

 

Grading

 G1

23

13.1

 G2

112

64.0

 G3

40

22.9

missing

47

 
  1. Percentages may not equal 100 due to rounding
  2. SD standard deviation, IQ first quartile, IIIQ third quartile, ECOG Eastern Cooperative Oncology Group, PS performance status